Amgen (AMGN) PT Lowered to $216 at RBC Capital
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $344.86 +2.15%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $216.00 (from $217.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
- Southern Co. (SO) PT Lowered to $99 at Jefferies
- Amgen (AMGN) PT Raised to $303 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
